- Home
- Publications
- Publication Search
- Publication Details
Title
Avoiding Drug Resistance in HIV Reverse Transcriptase
Authors
Keywords
-
Journal
CHEMICAL REVIEWS
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2021-01-29
DOI
10.1021/acs.chemrev.0c00967
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural basis for strand-transfer inhibitor binding to HIV intasomes
- (2020) Dario Oliveira Passos et al. SCIENCE
- Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial
- (2020) Dirk Schürmann et al. Lancet HIV
- Evolving understanding of HIV-1 reverse transcriptase structure, function, inhibition, and resistance
- (2020) Francesc Xavier RUIZ et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
- (2020) Calvin J. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
- (2020) Richard T. Eastman et al. ACS Central Science
- CMCdG, a novel nucleoside analog, exerts potent activity against wild-type and entecavir-resistant HBV with favorable safety feature
- (2019) Nobuyo Higashi-Kuwata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Active-site deformation in the structure of HIV-1 RT with HBV-associated septuple amino acid substitutions rationalizes the differential susceptibility of HIV-1 and HBV against 4ʹ-modified nucleoside RT inhibitors
- (2019) Yoshiaki Yasutake et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Once-Weekly Oral Dosing of MK-8591 Protects Male Rhesus Macaques From Intrarectal Challenge With SHIV109CP3
- (2019) Martin Markowitz et al. JOURNAL OF INFECTIOUS DISEASES
- Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus
- (2019) Enzo Tramontano et al. ANTIVIRAL RESEARCH
- Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment
- (2019) Yali Wang et al. Expert Opinion on Drug Metabolism & Toxicology
- Human Immunodeficiency Virus-1 Viral Load Is Elevated in Individuals With Reverse-Transcriptase Mutation M184V/I During Virological Failure of First-Line Antiretroviral Therapy and Is Associated With Compensatory Mutation L74I
- (2019) J Gregson et al. JOURNAL OF INFECTIOUS DISEASES
- Structural Basis of HIV-1 Inhibition by Nucleotide-Competing Reverse Transcriptase Inhibitor INDOPY-1
- (2019) F. Xavier Ruiz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Determinants of Active-Site Inhibitor Interaction with HIV-1 RNase H
- (2019) Zhaoyong Xi et al. ACS Infectious Diseases
- Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): Our past twenty years
- (2019) Chunlin Zhuang et al. Acta Pharmaceutica Sinica B
- Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H
- (2019) Lei Wang et al. ACCOUNTS OF CHEMICAL RESEARCH
- Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality
- (2018) Angie N. Pinto et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Extended Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and Prevention
- (2018) Stephanie E. Barrett et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structure-based design of targeted covalent inhibitors
- (2018) Richard Lonsdale et al. CHEMICAL SOCIETY REVIEWS
- Update on Recent Developments in Small Molecular HIV-1 RNase H Inhibitors (2013-2016): Opportunities and Challenges
- (2018) Xueshun Wang et al. CURRENT MEDICINAL CHEMISTRY
- 6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones potently and selectively inhibited HIV reverse transcriptase-associated RNase H
- (2018) Lei Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Emerging reverse transcriptase inhibitors for HIV-1 infection
- (2018) Mohammad A. Rai et al. EXPERT OPINION ON EMERGING DRUGS
- Pharmacokinetics studies of 4′-cyano-2′-deoxyguanosine, a potent inhibitor of the hepatitis B virus, in rats
- (2018) Mai Hashimoto et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
- (2018) Maria L. Agostini et al. mBio
- 4′-Ethynyl-2-fluoro-2′-deoxyadenosine, MK-8591
- (2018) Martin Markowitz et al. Current Opinion in HIV and AIDS
- The Transmission and Evolution of HIV-1 Quasispecies within One Couple: a Follow-up Study based on Next-Generation Sequencing
- (2018) Fengjiao Yu et al. Scientific Reports
- The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic
- (2018) Vigneshwaran Namasivayam et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H
- (2017) Jayakanth Kankanala et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Double-Winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity
- (2017) Sanjeev Kumar V. Vernekar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: From design to protein crystallography
- (2017) Albert H. Chan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A supramolecular assembly mediates lentiviral DNA integration
- (2017) Allison Ballandras-Colas et al. SCIENCE
- Redox-based reagents for chemoselective methionine bioconjugation
- (2017) Shixian Lin et al. SCIENCE
- Targeted Covalent Inhibitors for Drug Design
- (2016) Thomas A. Baillie ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Doravirine Suppresses Common Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutants at Clinically Relevant Concentrations
- (2016) Meizhen Feng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibition of HIV-1 Reverse Transcriptase Dimerization by Small Molecules
- (2016) Cristina Tintori et al. CHEMBIOCHEM
- Rilpivirine and Doravirine have complementary efficacies against NNRTI-Resistant HIV-1 mutants
- (2016) Steven J. Smith et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions
- (2016) Paul A. Jackson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H
- (2016) Jayakanth Kankanala et al. JOURNAL OF MEDICINAL CHEMISTRY
- Computational protein–ligand docking and virtual drug screening with the AutoDock suite
- (2016) Stefano Forli et al. Nature Protocols
- Structural basis of HIV inhibition by translocation-defective RT inhibitor 4′-ethynyl-2-fluoro-2′-deoxyadenosine (EFdA)
- (2016) Zhe Li Salie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Allosteric HIV-1 integrase inhibitors promote aberrant protein multimerization by directly mediating inter-subunit interactions: Structural and thermodynamic modeling studies
- (2016) Nanjie Deng et al. PROTEIN SCIENCE
- Design, Conformation, and Crystallography of 2-Naphthyl Phenyl Ethers as Potent Anti-HIV Agents
- (2016) Won-Gil Lee et al. ACS Medicinal Chemistry Letters
- Pharmacokinetics of Long-Acting Tenofovir Alafenamide (GS-7340) Subdermal Implant for HIV Prophylaxis
- (2015) Manjula Gunawardana et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Subtype-Specific Analysis of the K65R Substitution in HIV-1 That Confers Hypersusceptibility to a Novel Nucleotide-Competing Reverse Transcriptase Inhibitor
- (2015) Hong-Tao Xu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oral Administration of the Nucleoside EFdA (4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine) Provides Rapid Suppression of HIV Viremia in Humanized Mice and Favorable Pharmacokinetic Properties in Mice and the Rhesus Macaque
- (2015) Cheryl A. Stoddart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Alternative divalent cations (Zn2+, Co2+, and Mn2+) are not mutagenic at conditions optimal for HIV-1 reverse transcriptase activity
- (2015) Vasudevan Achuthan et al. BMC BIOCHEMISTRY
- Predicted residual activity of rilpivirine in HIV-1 infected patients failing therapy including NNRTIs efavirenz or nevirapine
- (2015) K. Theys et al. CLINICAL MICROBIOLOGY AND INFECTION
- Covalent protein modification: the current landscape of residue-specific electrophiles
- (2015) D Alexander Shannon et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Pre-Exposure Prophylaxis to Prevent HIV Infection: Current Status, Future Opportunities and Challenges
- (2015) Douglas S. Krakower et al. DRUGS
- 4′-modified nucleoside analogs: Potent inhibitors active against entecavir-resistant hepatitis B virus
- (2015) Yuki Takamatsu et al. HEPATOLOGY
- Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
- (2015) Paul E Sax et al. LANCET
- HIV-1 assembly, release and maturation
- (2015) Eric O. Freed NATURE REVIEWS MICROBIOLOGY
- Identification of mechanistically distinct inhibitors of HIV-1 reverse transcriptase through fragment screening
- (2015) Jennifer La et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of Highly Conserved Residues Involved in Inhibition of HIV-1 RNase H Function by Diketo Acid Derivatives
- (2014) Angela Corona et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Drug Resistance-Associated Amino Acid Changes in HIV-1 Subtype C on Susceptibility to Newer Nonnucleoside Reverse Transcriptase Inhibitors
- (2014) Adriaan E. Basson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroResistance Selection with Doravirine (MK-1439), a Novel Nonnucleoside Reverse Transcriptase Inhibitor with Distinct Mutation Development Pathways
- (2014) Meizhen Feng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent Progress in the Research of Small Molecule HIV-1 RNase H Inhibitors
- (2014) Lili Cao et al. CURRENT MEDICINAL CHEMISTRY
- In vitro transport characteristics of EFdA, a novel nucleoside reverse transcriptase inhibitor using Caco-2 and MDCKII cell monolayers
- (2014) Wei Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pre-exposure Prophylaxis for Human Immunodeficiency Virus
- (2014) Amanda D. Castel et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Tenofovir Alafenamide Vs. Tenofovir Disoproxil Fumarate in Single Tablet Regimens for Initial HIV-1 Therapy
- (2014) Paul E. Sax et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults
- (2014) M. Markowitz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- 4′-Ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) Inhibits HIV-1 Reverse Transcriptase with Multiple Mechanisms
- (2014) Eleftherios Michailidis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Design, Synthesis, Biochemical, and Antiviral Evaluations of C6 Benzyl and C6 Biarylmethyl Substituted 2-Hydroxylisoquinoline-1,3-diones: Dual Inhibition against HIV Reverse Transcriptase-Associated RNase H and Polymerase with Antiviral Activities
- (2014) Sanjeev Kumar V. Vernekar et al. JOURNAL OF MEDICINAL CHEMISTRY
- HIV and the spectrum of human disease
- (2014) Sebastian Lucas et al. JOURNAL OF PATHOLOGY
- Human Immunodeficiency Virus Reverse Transcriptase Displays Dramatically Higher Fidelity under Physiological Magnesium Conditions In Vitro
- (2014) V. Achuthan et al. JOURNAL OF VIROLOGY
- Mutations in HIV-1 Reverse Transcriptase Affect the Errors Made in a Single Cycle of Viral Replication
- (2014) M. E. Abram et al. JOURNAL OF VIROLOGY
- Mechanism of allosteric inhibition of HIV-1 reverse transcriptase revealed by single-molecule and ensemble fluorescence
- (2014) Grant D. Schauer et al. NUCLEIC ACIDS RESEARCH
- Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavir
- (2014) H. Hayashi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Advantages of crystallographic fragment screening: Functional and mechanistic insights from a powerful platform for efficient drug discovery
- (2014) Disha Patel et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Effects of Substitutions at the 4′ and 2 Positions on the Bioactivity of 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine
- (2013) Karen A. Kirby et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Combinations of 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine with Clinically Used Antiretroviral Drugs
- (2013) Atsuko Hachiya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase and Their Interactions with the M184I Mutation on Defining Patterns of Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Rilpivirine and Etravirine
- (2013) Hong-Tao Xu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroCharacterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor
- (2013) Ming-Tain Lai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dead-end complexes contribute to the synergistic inhibition of HIV-1 RT by the combination of rilpivirine, emtricitabine, and tenofovir
- (2013) Rima Kulkarni et al. ANTIVIRAL RESEARCH
- Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses
- (2013) Bernard Côté et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults
- (2013) Peter J. Ruane et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing
- (2013) George L. Melikian et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Improving the Resistance Profile of Hepatitis C NS3/4A Inhibitors: Dynamic Substrate Envelope Guided Design
- (2013) Ayşegül Özen et al. Journal of Chemical Theory and Computation
- Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening
- (2013) Joseph D. Bauman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Snapshot of the equilibrium dynamics of a drug bound to HIV-1 reverse transcriptase
- (2013) Daniel G. Kuroda et al. Nature Chemistry
- Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation
- (2013) K. A. Jurado et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability
- (2013) Iris Usach et al. Journal of the International AIDS Society
- HIV-1 Reverse Transcription
- (2013) W.-S. Hu et al. Cold Spring Harbor Perspectives in Medicine
- HIV-1 reverse transcriptase and antiviral drug resistance. Part 1
- (2013) Kalyan Das et al. Current Opinion in Virology
- HIV-1 reverse transcriptase and antiviral drug resistance. Part 2
- (2013) Kalyan Das et al. Current Opinion in Virology
- Panel of Prototypical Recombinant Infectious Molecular Clones Resistant to Nevirapine, Efavirenz, Etravirine, and Rilpivirine
- (2012) Maya Balamane et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Response of Simian Immunodeficiency Virus to the Novel Nucleoside Reverse Transcriptase Inhibitor 4′-Ethynyl-2-Fluoro-2′-DeoxyadenosineIn VitroandIn Vivo
- (2012) Michael Murphey-Corb et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biochemical Mechanism of HIV-1 Resistance to Rilpivirine
- (2012) Kamalendra Singh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks
- (2012) Tjeerd Barf et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rational Design of Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
- (2012) Pek Chong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mechanism for Effective Lymphoid Cell and Tissue Loading Following Oral Administration of Nucleotide Prodrug GS-7340
- (2012) Darius Babusis et al. MOLECULAR PHARMACEUTICS
- HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism
- (2012) Kalyan Das et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants
- (2012) Barry C Johnson et al. Retrovirology
- The HIV-1 Reverse Transcriptase M184I Mutation Enhances the E138K-Associated Resistance to Rilpivirine and Decreases Viral Fitness
- (2011) Rima Kulkarni et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Genotypic and Phenotypic Characterization of HIV-1 Isolates Obtained From Patients on Rilpivirine Therapy Experiencing Virologic Failure in the Phase 3 ECHO and THRIVE Studies
- (2011) Laurence Rimsky et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- The resurgence of covalent drugs
- (2011) Juswinder Singh et al. NATURE REVIEWS DRUG DISCOVERY
- Residual HIV-1 DNA Flap-independent nuclear import of cPPT/CTS double mutant viruses does not support spreading infection
- (2011) Candela Iglesias et al. Retrovirology
- Structures of Reverse Transcriptase Pre- and Post-Excision Complexes Shed New Light on HIV-1 AZT Resistance
- (2011) Walter A. Scott Viruses-Basel
- Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies
- (2010) Johan Vingerhoets et al. AIDS
- Characterization of Genotypic and Phenotypic Changes in HIV-1-Infected Patients with Virologic Failure on an Etravirine-Containing Regimen in the DUET-1 and DUET-2 Clinical Studies
- (2010) Lotke Tambuyzer et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Combinations of Mutations in the Connection Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Assessing the Impact on Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitor Resistance
- (2010) S. Gupta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations
- (2010) Elizabeth C. Reuman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The N348I Mutation at the Connection Subdomain of HIV-1 Reverse Transcriptase Decreases Binding to Nevirapine
- (2010) Matthew M. Schuckmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The HIV-1 Central Polypurine Tract Functions as a Second Line of Defense against APOBEC3G/F
- (2010) C. Hu et al. JOURNAL OF VIROLOGY
- Nature, Position, and Frequency of Mutations Made in a Single Cycle of HIV-1 Replication
- (2010) M. E. Abram et al. JOURNAL OF VIROLOGY
- Evaluating the Substrate-Envelope Hypothesis: Structural Analysis of Novel HIV-1 Protease Inhibitors Designed To Be Robust against Drug Resistance
- (2010) M. N. L. Nalam et al. JOURNAL OF VIROLOGY
- Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication
- (2010) Frauke Christ et al. Nature Chemical Biology
- Structural basis of HIV-1 resistance to AZT by excision
- (2010) Xiongying Tu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and Inhibitors
- (2010) Greg L. Beilhartz et al. Viruses-Basel
- HIV virology and pathogenetic mechanisms of infection: a brief overview
- (2010) Emanuele Fanales-Belasio et al. ANNALI DELL ISTITUTO SUPERIORE DI SANITA
- TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1
- (2009) H. Azijn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)
- (2009) Marie-Pierre de Béthune ANTIVIRAL RESEARCH
- Structural Basis for the Role of the K65R Mutation in HIV-1 Reverse Transcriptase Polymerization, Excision Antagonism, and Tenofovir Resistance
- (2009) Kalyan Das et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mechanism of Inhibition of HIV-1 Reverse Transcriptase by 4′-Ethynyl-2-fluoro-2′-deoxyadenosine Triphosphate, a Translocation-defective Reverse Transcriptase Inhibitor
- (2009) Eleftherios Michailidis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small Molecule Inhibitors Targeting HIV-1 Reverse Transcriptase Dimerization
- (2008) Dina Grohmann et al. CHEMBIOCHEM
- 2′-Deoxy-4′-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants
- (2008) Atsushi Kawamoto et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against “Nucleotide-competing Reverse Transcriptase Inhibitors”
- (2008) Maryam Ehteshami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition
- (2008) Stefan G. Sarafianos et al. JOURNAL OF MOLECULAR BIOLOGY
- High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: Strategic flexibility explains potency against resistance mutations
- (2008) K. Das et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
- (2008) B. F. Keele et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Small-Molecule CD4 Mimics Interact with a Highly Conserved Pocket on HIV-1 gp120
- (2008) Navid Madani et al. STRUCTURE
- RNase H activity: Structure, specificity, and function in reverse transcription
- (2008) Sharon J. Schultz et al. VIRUS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search